Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan A Hahn

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Nature Medicine|September 22, 2015
Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinomaPawel K Mazur, Alexander Herner, Stephano S Mello, et al.
Nature Medicine|May 30, 2024
Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinomaPawel K Mazur, Alexander Herner, Stephano S Mello, et al.
Nature Medicine|January 29, 2026
Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinomaPawel K Mazur, Alexander Herner, Stephano S Mello, et al.
International Journal of Cancer|June 2, 2004
Prevalence of familial pancreatic cancer in GermanyDetlef K Bartsch, Ralf Kress, Mercedes Sina-Frey, et al.
Genome Medicine|July 17, 2021
Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer modelsDeepak Vangala, Swetlana Ladigan, Sven T Liffers, et al.
Gastroenterology|November 1, 2023
An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational TherapiesMarie C Hasselluhn, Denise Schlösser, Lennart Versemann, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Nature Medicine|September 22, 2015
Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinomaPawel K Mazur, Alexander Herner, Stephano S Mello, et al.
Nature Medicine|May 30, 2024
Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinomaPawel K Mazur, Alexander Herner, Stephano S Mello, et al.
Nature Medicine|January 29, 2026
Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinomaPawel K Mazur, Alexander Herner, Stephano S Mello, et al.
International Journal of Cancer|June 2, 2004
Prevalence of familial pancreatic cancer in GermanyDetlef K Bartsch, Ralf Kress, Mercedes Sina-Frey, et al.
Genome Medicine|July 17, 2021
Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer modelsDeepak Vangala, Swetlana Ladigan, Sven T Liffers, et al.
Gastroenterology|November 1, 2023
An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational TherapiesMarie C Hasselluhn, Denise Schlösser, Lennart Versemann, et al.
Pageof 9